MBTPS2 and cerebral malaria: Importantly, after controlled sporozoite injection, none of the s2p(-) infected mice exhibited symptoms of experimental cerebral malaria (ECM), which typically develop at day 7–9 after infection, as seen in most (7/9) WT-infected mice (Fig 6C).